Literature DB >> 25784597

HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Kuppusamy Balamurugan1.   

Abstract

The complex cross-talk of intricate intercellular signaling networks between the tumor and stromal cells promotes cancer progression. Hypoxia is one of the most common conditions encountered within the tumor microenvironment that drives tumorigenesis. Most responses to hypoxia are elicited by a family of transcription factors called hypoxia-inducible factors (HIFs), which induce expression of a diverse set of genes that assist cells to adapt to hypoxic environments. Among the three HIF protein family members, the role of HIF-1 is well established in cancer progression. HIF-1 functions as a signaling hub to coordinate the activities of many transcription factors and signaling molecules that impact tumorigenesis. This mini review discusses the complex role of HIF-1 and its context-dependent partners under various cancer-promoting events including inflammation and generation of cancer stem cells, which are implicated in tumor metastasis and relapse. In addition, the review highlights the importance of therapeutic targeting of HIF-1 for cancer prevention.
© 2015 UICC.

Entities:  

Keywords:  HIF-1; cancer stem cells; drug resistance; hypoxia; inflammation; microenvironment

Mesh:

Substances:

Year:  2015        PMID: 25784597      PMCID: PMC4573780          DOI: 10.1002/ijc.29519

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  153 in total

1.  Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

Authors:  Richa Tewari; Saurav Roy Choudhury; Sadashib Ghosh; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2011-09-02       Impact factor: 4.599

Review 2.  Hypoxia-inducible factors as key regulators of tumor inflammation.

Authors:  Soulafa Mamlouk; Ben Wielockx
Journal:  Int J Cancer       Date:  2012-11-02       Impact factor: 7.396

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Zhao Lin; Adam Ertel; Neal Flomenberg; Agnieszka K Witkiewicz; Ruth C Birbe; Anthony Howell; Stephanos Pavlides; Ricardo Gandara; Richard G Pestell; Federica Sotgia; Nancy J Philp; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

5.  The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia.

Authors:  Konstantin Salnikow; Thomas Kluz; Max Costa; David Piquemal; Zoya N Demidenko; Keping Xie; Mikhail V Blagosklonny
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 6.  Effects of histone deacetylase inhibitors on HIF-1.

Authors:  Dongming Liang; Xianguo Kong; Nianli Sang
Journal:  Cell Cycle       Date:  2006-09-13       Impact factor: 4.534

Review 7.  Cadherins and epithelial-to-mesenchymal transition.

Authors:  Alexander Gheldof; Geert Berx
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

9.  Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast.

Authors:  Hirotaka Nishi; Toshihide Nakada; Mitsuyasu Hokamura; Yumi Osakabe; Osamu Itokazu; L Eric Huang; Keiichi Isaka
Journal:  Endocrinology       Date:  2004-05-20       Impact factor: 4.736

Review 10.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

View more
  150 in total

Review 1.  Present and future of cancer immunotherapy: A tumor microenvironmental perspective.

Authors:  Yu Yu; Jiuwei Cui
Journal:  Oncol Lett       Date:  2018-07-26       Impact factor: 2.967

2.  Methods to Monitor Mitophagy and Mitochondrial Quality: Implications in Cancer, Neurodegeneration, and Cardiovascular Diseases.

Authors:  Simone Patergnani; Massimo Bonora; Esmaa Bouhamida; Alberto Danese; Saverio Marchi; Giampaolo Morciano; Maurizio Previati; Gaia Pedriali; Alessandro Rimessi; Gabriele Anania; Carlotta Giorgi; Paolo Pinton
Journal:  Methods Mol Biol       Date:  2021

3.  Correlation of Hypoxia-inducible facto-1α and C-reactive protein with disease evaluation in patients with ulcerative colitis.

Authors:  Shuxia Yu; Bin Li; Jinghua Hao; Xiuju Shi; Jian Ge; Hongwei Xu
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Hypoxia-inducible factor 1α participates in hypoxia-induced epithelial-mesenchymal transition via response gene to complement 32.

Authors:  Liang Zhu; Qiu Zhao
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

5.  On the relationships in rhesus macaques between chronic ethanol consumption and the brain transcriptome.

Authors:  Ovidiu D Iancu; Alexander Colville; Nicole A R Walter; Priscila Darakjian; Denesa L Oberbeck; James B Daunais; Christina L Zheng; Robert P Searles; Shannon K McWeeney; Kathleen A Grant; Robert Hitzemann
Journal:  Addict Biol       Date:  2017-02-28       Impact factor: 4.280

Review 6.  How do cancer cells replenish their fuel supply?

Authors:  Abdallah K Alameddine; Frederick T Conlin; Brian J Binnall; Yvonne A Alameddine; Khaled O Alameddine
Journal:  Cancer Rep (Hoboken)       Date:  2018-04-30

7.  Co-expression of HIF-1 and TLR3 is associated with poor prognosis in oral squamous cell carcinoma.

Authors:  Shengwei Han; Xiteng Yin; Yufeng Wang; Wenguang Xu; Wei Cheng
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 8.  Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.

Authors:  Jenna L Carter; Katie Hege; Jay Yang; Hasini A Kalpage; Yongwei Su; Holly Edwards; Maik Hüttemann; Jeffrey W Taub; Yubin Ge
Journal:  Signal Transduct Target Ther       Date:  2020-12-18

Review 9.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

Authors:  Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

Review 10.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.

Authors:  Debashree Basudhar; Veena Somasundaram; Graciele Almeida de Oliveira; Aparna Kesarwala; Julie L Heinecke; Robert Y Cheng; Sharon A Glynn; Stefan Ambs; David A Wink; Lisa A Ridnour
Journal:  Antioxid Redox Signal       Date:  2016-09-07       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.